"the breast" trang 7 - tải miễn phí từ tailieuXANH
Shifting breast cancer surveillance from current hospital setting to a community based setting: A cost-effectiveness study

Shifting breast cancer surveillance from current hospital setting to a community based setting: A cost-effectiveness study
10    97    0
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
9    80    0
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
6    75    0
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature

It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature
8    64    0
Pregnancy-associated breast cancer in rural Rwanda: The experience of the Butaro Cancer Center of Excellence

Pregnancy-associated breast cancer in rural Rwanda: The experience of the Butaro Cancer Center of Excellence
8    92    0
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    92    0
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study
7    81    0
Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+ /EpCAM+ phenotype: A promising target for preventing progression of TNBC

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+ /EpCAM+ phenotype: A promising target for preventing progression of TNBC
11    154    0
BRCA2 carriers with male breast cancer show elevated tumour methylation

BRCA2 carriers with male breast cancer show elevated tumour methylation
11    72    0
Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers
10    75    0
MiR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triplenegative breast cancer

MiR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triplenegative breast cancer
13    76    0
Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer

Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer
10    90    0
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
16    106    0
Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer
21    142    0
Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway
11    148    0
Effect of neoadjuvant therapy on breast cancer biomarker profile

Effect of neoadjuvant therapy on breast cancer biomarker profile
9    116    0
CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer
13    104    0
Tamoxifen reverses epithelial – mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

Tamoxifen reverses epithelial – mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
12    108    0
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
11    99    0
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
9    100    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.